Isolated Mesenteric Calciphylaxis With Ischemic Colitis in a Hemodialysis Patient Without Active Cutaneous

Rachel Yi Ping Tan1,2, Rajiv Juneja1,2, Dimuth Nilanga Gunawardane3

  • 1Renal Unit, Flinders Medical Centre, South Australia, Australia.

Kidney Medicine
|August 1, 2020
PubMed

Insights

Calciphylaxis, or calcific uremic arteriolopathy, is a severe kidney disease complication. This case highlights isolated mesenteric calciphylaxis, a rare form without skin lesions, presenting treatment and transplant challenges.

Area of Science:

  • Nephrology
  • Vascular Biology
  • Gastroenterology

Background:

  • Calciphylaxis (calcific uremic arteriolopathy) is a severe systemic disease linked to chronic kidney failure.
  • Histopathology reveals small-vessel calcification, intimal hyperplasia, and microthrombi, causing tissue necrosis.
  • Typically presents as painful cutaneous lesions; visceral involvement is rare and usually co-occurs with skin lesions.

Observation:

  • A case report of a male patient undergoing hemodialysis who presented with mesenteric calciphylaxis and ischemic colitis.
  • Notably, this patient had no active cutaneous lesions, distinguishing it from previously documented cases of visceral calciphylaxis.
  • The patient had a history of penile calciphylaxis, which had healed 12 months prior to the mesenteric presentation.

Findings:

  • This case represents the first documented instance of isolated mesenteric calciphylaxis.
  • Treatment involved sodium thiosulfate, vitamin K, and surgical resection of the affected mesenteric tissue.
  • The patient's prior penile calciphylaxis was treated with sodium thiosulfate and management of mineral and bone disorder parameters.

Implications:

  • This case highlights the potential for calciphylaxis to manifest in visceral organs without cutaneous involvement, posing diagnostic challenges.
  • It raises critical questions regarding optimal duration of sodium thiosulfate therapy, methods for monitoring disease activity, and the implications for kidney transplant eligibility.
  • Further research is needed to understand the pathophysiology and management of isolated visceral calciphylaxis.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
246
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
427
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
391
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
288
Urinary Tract Calculi V: Nursing Management01:28

Urinary Tract Calculi V: Nursing Management

AssessmentSubjective Data: Obtain a detailed health history, including any recent or chronic urinary tract infections, periods of immobilization, previous episodes of renal calculi, and medical conditions such as gout, benign prostatic hyperplasia, or hyperparathyroidism. Review the medication history for drugs that may influence stone formation, including allopurinol, analgesics, loop diuretics, or thiazide diuretics. Document the use of long-term indwelling catheters and any past surgical...
181
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
279